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Identification of IL18RAP/IL18R1 and IL12B
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Chunying Yuan,2,3 Nan Lu,2,3 Jiabao You,2,3 Fangfang Bao,2,3 Jinghui Li,2,3 Jian Liu,2,3 Huaxu Liu,2,3
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Of eight leprosy susceptibility loci identified by genome-wide association studies, five have been implicated in Crohn disease, suggesting
a common genetic fingerprint between leprosy and inflammatory bowel disease (IBD). Here, we conducted a multiple-stage genetic asso-
ciation study of 133 IBD susceptibility loci in multiple leprosy samples (totaling 4,971 leprosy cases and 5,503 controls) from a Chinese
population and discovered two associations at rs2058660 on 2q12.1 (p¼ 4.573 1019; odds ratio [OR]¼ 1.30) and rs6871626 on 5q33.3
(p¼ 3.953 1018; OR¼ 0.75), implicating IL18RAP/IL18R1 and IL12B as susceptibility genes for leprosy. Our study reveals the important
role of IL12/IL18-mediated transcriptional regulation of IFN-g production in leprosy, and together with previous findings, it demon-
strates the shared genetic susceptibility between infectious and inflammatory diseases.Genome-wide association studies (GWASs) have offered
a powerful and unbiased approach for the identification
of susceptibility genes for complex diseases. As of
September 2011, a total of 1,617 susceptibility loci have
been identified in 249 complex traits (see Web Resources
for the Catalog of Published GWASs). The enormous prog-
ress of GWASs has led to the revelation of biological
connections between some clinically unrelated diseases
through the identification of shared risk variants; such
connections include associations between IL23R (MIM
607562) variants and leprosy (MIM 609888),1 Crohn
disease (CD [MIM 266600]),2 ulcerative colitis (UC [MIM
266600]),3 psoriasis (MIM 177900),4 and ankylosing spon-
dylitis (AS [MIM 106300]),5 as well as the association
between PTPN2 (MIM 176887) variants and CD2 and
type 1 diabetes (IDDM [MIM 222100]).6
Of the eight leprosy susceptibility loci identified by
GWASs,1,7 variants of NOD2 (16q12 [MIM 605956]),
TNFSF15 (9q32 [MIM 604052]), LRRK2 (12q12[MIM
609007]), IL23R (1p31.3), and LACC1/CCDC122 (13q14.11
[MIM 613409 and 613408]) have also been reported to be
associated with CD and UC, suggesting a strong biological
link among the genetic susceptibilities of these diseases.
Both CD and UC belong to inflammatory bowel disease
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The Americantinal mucosa. Recent GWAS analyses of CD and UC have
corroborated that nearly one-third of their susceptibility
loci are shared.8 Leprosy is a chronic infectious disease
caused by Mycobacterium leprae and affects both the skin
and the peripheral nerves. Although leprosy and CD are
distinct clinical entities, they both belong to chronic
inflammatory diseases, and there is some suggestive
evidence that they share pathogenic mechanisms. For
example, the formation of granuloma is an important
clinical hallmark of both leprosy and CD. In addition, it
has also been suggested that the development of CD, at
least in some individuals, might be triggered by myco-
bacterial infection.9,10 Mycobacterium avium subspecies
paratuberculosis has been cultured and identified from the
intestines and blood of CD-affected individuals.11 It has
also been hypothesized that CD susceptibility genes,
such as NOD2, might interact with mycobacterium trig-
gers.12 Moreover, multibacillary infection of leprosy is
associated with a type 2 helper T (Th2) cell response,
whereas paucibacillary infection is associated with an
immune response mediated by type 1 helper T (Th1)
cells.13 The development of IBD shows a similar pattern
in which tissue injury was thought to be primarily medi-
ated by Th1 cells in CD14 and by Th2 cells in UC.15 We
therefore hypothesized that there are additional sharedcademy of Medical Sciences, Jinan, Shandong 250022, China; 2Shandong
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Table 1. Summary of the Four Independent Leprosy Samples Used in the Current Study
Cases Controls
Ethnicity Sample Size Mean Age Mean Age at Onset Male/Female Sample Size Mean Age Male/Female
Sample 1a Han 1,504 66.22 22.96 1,251/253 1,502 65.25 1,254/248
Sample 2b Han 1,154 66 23.57 934/220 2,605 57.01 1,313/1,292
Sample 3c Han 1,165 62.36 32.73 846/319 648 42.09 275/373
Sample 4d Chuang 334 54.76 24.68 224/110 310 45.6 195/115
Miao 277 53.03 27.88 193/84 190 41.48 152/38
Yizu 236 54.37 26.71 166/70 182 43.77 147/35
other 301 56.90 26.84 212/89 66 42.18 26/40
Total 4,971 62.63 26.19 3,826/1,145 5,503 55.71 3,362/2,141
aSamples collected in Shandong, Anhui, and Jiangsu provinces (eastern China).
bSamples collected in Shandong, Anhui, and Jiangsu provinces (eastern China).
cSamples collected in Yunnan, Guizhou, and Fujian provinces (southern China).
dSamples collected in Yunnan, Guizhou, and Fujian provinces (southern China).susceptibility loci between leprosy and IBD and searched
for more leprosy susceptibility genes by carrying out a
comprehensive association study of IBD susceptibility
loci in multiple independent leprosy samples from a
Chinese population.
We reviewed the findings from 12 CD GWASs and
seven UC GWASs through the Catalog of Published
GWASs and identified within 118 genes a total of 155
SNPs that showed genome-wide significant associations
(p values < 5.0 3 108) with CD, UC, or both. Of the
155 SNPs, we excluded seven within the major-histocom-
patibility-complex region and 15 SNPs within the five
known leprosy susceptibility genes (NOD2, TNFSF15,
IL23R, LACC1, and LRRK2). After exclusion, a total of
133 SNPs, including 75 CD-associated SNPs, 54 UC-associ-
ated SNPs, and four IBD (both CD and UC)-associated
SNPs, were selected for multistage association study in
the four independent leprosy samples from the Chinese
population.
We conducted genotyping analyses of the four leprosy
samples by using the Sequenom MassArray system (San
Diego, USA). In stage 1, all 133 selected SNPs were geno-
typed in 1,504 leprosy cases and 1,502 healthy controls
from a northern Chinese Han population. Of the 119
SNPs that were successfully designed and genotyped,
19 showed suggestive association (p < 0.05) in stage 1
analysis and included nine CD-associated SNPs, eight
UC-associated SNPs, and two IBD-associated SNPs (Table
S1, available online). In stage 2, the 19 SNPs were further
genotyped in an additional three independent leprosy
cohorts from the Chinese population: (1) 1,154 cases
and 2,605 controls from a northern Chinese Han popu-
lation, (2) 1,165 cases and 648 controls from a southern
Chinese Han population, and (3) 1,148 case and 748
control minorities from southern China (Table 1). The
study was approved by the institutional review board
at the Shandong Provincial Institute of Dermatology and936 The American Journal of Human Genetics 91, 935–941, NovembVenereology, and informed consent was obtained from
all individuals.
In each of the four independent leprosy cohorts, those
SNPs with a call rate < 95%, a low minor allele frequency
(<0.01), or a deviation from Hardy-Weinberg equilibrium
(p < 0.01) in the controls were excluded. We adopted
a Cochran-Armitage trend test to test the genotype-
phenotype association in each sample, and we performed
the final analysis of the combined samples by using the
Cochran-Mantel-Haenszel test. Q-tests were performed
for evaluating the significance of heterogeneity among
individual studies, and p values < 0.05 were considered
to be significant heterogeneity.
Two associations were discovered: one at rs2058660
on 2q12.1 and one at rs6871626 on 5q33.3. Both of the
SNPs showed consistent association across the four
independent samples without any indication of genetic
heterogeneity (p > 0.05). In the combined samples of a
total of 4,971 cases and 5,503 controls, the associations
at the two SNPs suppressed the genome-wide significance
(combined p ¼ 4.57 3 1019 and odds ratio [OR] ¼ 1.30
for rs2058660; combined p ¼ 3.95 3 1018 and OR ¼
0.75 for rs6871626) (Table 2).
We further investigated the association evidence
within the surrounding regions of the two loci by using
our previously published GWAS data set.1 To maximize
the coverage of genetic variants, we imputed the
GWAS data set by using the genetic-variation data
from the 1000 Genomes Project (version from February
2012), which includes 1,092 individuals from Africa
(246 samples), North America (181 samples), Asia (286
samples), and Europe (379 samples). Imputed genotypes
with a probability < 90%, as well as SNPs with impu-
tation certainty < 80%, a MAF < 5%, and a missing
rate > 1% were excluded from further analysis. In total,
there were 6,593 samples (706 individuals with leprosy
and 5,587 controls subjects) and 1,987,713 SNPs thater 2, 2012
Table 2. Summary of the Association Results for the Two
Confirmed Loci in Four Independent Samples and the Combined
Samples
SNP
rs2058660 rs6871626
Chromosome 2 5
Position 103,054,449 158,826,792
Minor/major allele T/C A/C
Test allelea T A
Gene IL18RAP/IL18R1 IL12B
AFb 0.49 0.35
Sample 1
p 5.67 3 1010 2.75 3 105
OR 1.41 0.77
95% CI 1.26–1.56 0.69–0.87
Sample 2
p 7.29 3 107 7.01 3 107
OR 1.29 0.75
95% CI 1.17–1.42 0.67–0.84
Sample 3
p 8.34 3 103 1.59 3 103
OR 1.20 0.78
95% CI 1.05–1.38 0.67–0.91
Sample 4
p 4.52 3 104 6.29 3 107
OR 1.28 0.69
95% CI 1.12–1.47 0.60–0.80
All Samples Combined
p 4.57 3 1019 3.95 3 1018
OR 1.30 0.75
95% CI 1.23–1.38 0.71–0.81
Q-test 0.35 0.58
The following abbreviations are used: AF, average allele frequency; OR,
odds ratio; and CI, confidence interval.
aTest allele: the allele that was used for estimating the OR.
bAF of the test allele in the controls of the four independent samples.passed quality control and remained in the association
analysis.
We found rs2058660 to be located within a linkage-
disequilibrium (LD) block of about 480 kb on 2q12.1 (Fig-
ure 1A). Besides rs2058660 (p ¼ 1.49 3 103; OR ¼ 1.22),
additional associations (p < 5.00 3 103) were also ob-
served at a large number of surrounding SNPs; the most
significant association was at rs1916307 (p ¼ 7.11 3 104;
OR ¼ 1.24). Conditioning on the top SNP, rs1916307,
abolished the association at rs2058660, as well as asso-
ciations at the surrounding SNPs (pconditional > 0.1). In
addition to the reported CD association at rs2058660,The Americangenome-wide significant associations were also reported
within the regions for asthma (at rs3771166)16 and celiac
disease (MIM 212750) (at rs917997 and rs13015714).17,18
Although asthma-associated rs3771166 (p ¼ 9.91 3 101;
OR ¼ 1.00) did not show any evidence of association in
our previous GWAS data set, the two celiac-disease-related
SNPs (p¼ 1.643 103 and p¼ 1.923 103) did show asso-
ciation. However, these two SNPs were in strong LD with
rs2058660 (r2 > 0.8), and their associations were therefore
not independent from the one at rs2058660. Intriguingly,
we found the associations between rs2058660 and leprosy
and CD to be in the direction opposite of that of the
T allele, suggesting that this SNP is a risk variant for
leprosy but a protective variant for CD. Our study has indi-
cated that the susceptibility locus for leprosy on 2q12.1
is also associated with CD and celiac disease but has the
opposite genetic effect (Table S2).
We found rs6871626 to be located within a small LD
block of 40 kb on 5q33 (Figure 1B). Besides rs6871626,
six surrounding SNPs showed stronger association with
the most significant SNP at rs1422877 (p ¼ 2.93 3 104;
OR ¼ 0.78). These six SNPs were in high LD (r2 > 0.8)
and were not independent from each other. Conditioning
on the top SNP, rs1422877, eliminated the association
at rs6871626 (pconditional ¼ 0.49). SNP rs6871626 was
reported to be associated with UC.3 The associations
between rs6871626 and leprosy and UC were in the direc-
tion opposite of that of the C allele, suggesting that
this SNP is a risk variant for leprosy but a protective allele
for UC. In addition to the reported UC association at
rs6871626, genome-wide significant association was
also reported for CD (rs10045431 and rs6887695),2,19
multiple sclerosis (MS [MIM 126200]) (rs10866713 and
rs2546890),20 psoriasis (rs2546890, rs3213094, and
rs2082412),4,21,22 psoriatic arthritis (PSA [MIM 607507])
(rs12188300),23 and AS (rs6556416).5 However, none of
these previously reported SNPs showed association with
leprosy (p > 0.10) in our previously published GWAS
data set, although our power calculation indicated that
our GWAS data set should provide sufficient power
(>80%) to detect these associations at p ¼ 0.05. Further-
more, none of these previously reported SNPs were in LD
with rs6871626 (r2 < 0.01), and they (except for
rs12188300) were separated from rs6871626 by a strong
recombination hot spot. All together, our analyses have
indicated that the leprosy susceptibility locus at 5q33.3 is
also involved in the development of UC but is indepen-
dent from the previously published associations with
CD,MS, psoriasis, PSA, and ASwithin the region (Table S2).
The LD region of the leprosy susceptibility locus on
2q12.1 contained five genes: IL1RL1 (MIM 601203),
IL18RAP (MIM 604509), IL18R1 (MIM 604494), SLC9A4
(MIM 600531), and SLC9A2 (MIM 600530) (Figure 1A).
IL1RL1, IL18RAP, and IL18R1 are part of the cytokine
receptor cluster on 2q12. Whereas IL1RL1 encodes the
receptor of IL33, IL18RAP and IL18R1 encode the receptors
of IL18. IL33 is a ligand that is selectively expressed onJournal of Human Genetics 91, 935–941, November 2, 2012 937
Figure 1. Regional Association Plots of rs2058660 and rs6871626
The p values of SNPs (shown as log10p) (y axis) are plotted against their map positions (x axis). The color of each SNP spot reflects its r2
with the confirmed SNP within each locus. The confirmed SNP, the top SNP, and previously reported SNPs of each locus are all in
pink and are labeled with arrows. Estimated recombination rates (based on the combined CHB [Han Chinese in Beijing, China] and
JPT [Japanese in Tokyo, Japan] samples from the 1000 Genomes Project) are plotted in light blue. Gene annotations were adapted
from the UCSC Genome Browser (see Web Resources).
(A) rs2058660 on 2q12.1.
(B) rs6871626 on 5q33.3.Th2 cells and mast cells and potently drives production
of Th2-associatied cytokines. The signaling of different
isoforms of IL1RL1 binding to IL33 plays diverse roles in
the activation of nuclear factor kB (NFkB) and the subse-938 The American Journal of Human Genetics 91, 935–941, Novembquent inflammatory response.24,25 Binding of IL18 to its
receptors stimulates both Th1 and Th2 cytokine release
and ultimately leads to the activation of NF-kB, which is
a central element in the pathogenesis of leprosy.7 It haser 2, 2012
also been reported that IL18 can promote Th1 responses
specific to M. leprae and can enhance IFN-g production
from natural-killer cells and Ag-stimulated T cells in
response to M. Leprae.26 In vitro, monocytes produce
IL18 in response to M. leprae.27
The association at 5q33.3 was located within a small
LD region in which only one unannotated transcript
(LOC285627) could be found. However, IL12B (MIM
161561) is located next to the LD region and is a strong
biological candidate (Figure 1B). IL12B encodes the p40
subunit of both heterodimeric interleukins IL12 and
IL23, which play an important role in Th17-cell-mediated
chronic inflammation by promoting Th17 cell mainte-
nances and the production of proinflammatory cyto-
kines.28 In addition, IL12B has also been reported to play
a role in increased susceptibility to tuberculosis (MIM
607948), although the reported association results were
not conclusive and were inconsistent across different
studies.29–31 Furthermore, in vitro studies have shown
that the expression of IL12B could be triggered by DNA
ofM. tuberculosis in dendritic cells through TLR9 signaling,
which in turn regulates the level of IFN-g production
during infection and that IL12B is required for the gene-
ration of activated CD4 T cells and dendritic cell migration
after M. tuberculosis infection.32,33
In particular, it has been demonstrated that the syner-
gistic action of IL18 and IL12 plays an important role in
IFN-g production.34 The synergistic action can be reflected
by the induction of the IL18 receptors by IL12; this in turn
leads to the induction of IL12 receptors in Th1 cells. The
synergistic action can also be seen in their cooperated
transcriptional regulation of IFN-g production—different
transcription factors activated by IL12 and IL18 can syner-
gistically activate the IFN-g promoter. Although further
fine mapping and functional investigations are needed
for confirming true susceptibility genes within these two
loci, our findings have strongly suggested that the IL12/
IL18-mediated transcriptional regulation of IFN-g pro-
duction plays an important role in the development of
leprosy.
Both IL12 and IL18 pathways have been shown to be
involved in the development of IBD. The IL12/IL23-
mediated Th17 pathway has been shown to play an
important role in the development of IBD, as well as
autoimmune diseases, such as psoriasis.28,35 In addition,
previous studies have shown that the balance between
IL18 and IL18-binding proteins might contribute to the
pathogenesis of IBD.36 IL18 expression is higher in the
mucosa of CD-affected individuals than in uninvolved
areas and normal controls.37 Mouse models for CD show
that blocking IL18 with an IL18-binding protein attenu-
ates the intestinal inflammation.38
It is intriguing to see that the two susceptibility loci
showed opposite associations between leprosy and IBD.
In addition, of the five known shared susceptibility loci
that were excluded from the current study, one SNP,
rs3764147, was also analyzed in both leprosy and IBD byThe Americanprevious studies (Table S3). According to the published
association results, the SNP showed consistent association
between leprosy and IBD. Although consistent association
between the two diseases supports the hypothesis that
Mycobacteria infection might trigger or enhance the devel-
opment of IBD, the opposite associations at rs2058660
and rs6871626 might suggest that historical selection
against infectious diseases (such as leprosy) might prompt
strong immunity whose overreaction might increase the
risk of developing inflammatory diseases (such as IBD).
Further studies are warranted for identifying the causal
variants of these susceptibility loci through fine mapp-
ing and functional investigation and for further under-
standing the complex genetic basis of shared susceptibility
between infectious and inflammatory diseases.
We also investigated the population-frequency differ-
ences of the reported IBD SNPs between Chinese and
European populations and evaluated the power of our
study to detect these previously reported IBD SNPs in our
leprosy samples. We used CaTs software to calculate power
by using a nominal significance of 0.05, the reported ORs
in the IBD GWAS catalogue, and allele frequencies from
the Chinese population. Regarding the 114 SNPs for
which power analysis was performed, our study had suffi-
cient (>80%) power to detect 35 SNPs, good (50%–80%)
power to detect 20 SNPs, and insufficient (<50%) power
to detect 59 SNPs (Table S4). Of these 59 SNPs, about half
had a substantially lower population frequency (by at least
30%) in the Chinese population than in the European
population. A much bigger study will be needed for inves-
tigating the role of these IBD SNPs in leprosy development.
In conclusion, we have discovered two susceptibility loci
for leprosy by carrying out a comprehensive association
study of IBD susceptibility loci in leprosy samples from
a Chinese population. The discovery of the two suscepti-
bility loci has implicated IL18RAP/IL18R1 and IL12B
as susceptibility genes for leprosy and highlighted the
important role of IL12/IL18-mediated transcriptional
regulation of IFN-g production in the development of
leprosy. Together with previous findings, our study has
further demonstrated the shared genetic susceptibility
basis between inflammation and infectious diseases.Supplemental Data
Supplemental Data include four tables and can be found with this
article online at http://www.cell.com/AJHG.Acknowledgments
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